Although Beclin1 haploinsufficiency failed to elicit any notable response on myocardial ultrastructure at basal or MI-challenged conditions, it effectively nullified MSCs-offered benefit against MI infarction (Fig. 5a-c). This evidence concerns the gene BECN1 and myocardial infarction.